Recovery after prolonged ICU treatment in patients with COVID-19

Affiliations

¹ Department of Anesthesia, University of Toronto, Toronto, ON M5G2M1, Canada; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON M5G2M1, Canada. Electronic address: matteo.parotto@uhn.ca.
² Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
³ Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK.
⁴ King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
⁵ Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain; Pulmonary Division, Heart Institute, Faculty of Medicine, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
⁶ Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON M5G2M1, Canada; Department of Medicine, University Health Network, Toronto, ON, Canada.

Matteo Parotto et al. Lancet Respir Med. 2021 Aug.

. 2021 Aug;9(8):812-814.

doi: 10.1016/S2213-2600(21)00318-0. Epub 2021 Jul 15.

¹ Department of Anesthesia, University of Toronto, Toronto, ON M5G2M1, Canada; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON M5G2M1, Canada. Electronic address: matteo.parotto@uhn.ca.
² Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
³ Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK.
⁴ King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
⁵ Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain; Pulmonary Division, Heart Institute, Faculty of Medicine, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
⁶ Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON M5G2M1, Canada; Department of Medicine, University Health Network, Toronto, ON, Canada.

No abstract available

Conflict of interest statement

We declare no competing interests.

1. Prescott HC. Outcomes for patients following hospitalization for COVID-19. JAMA. 2021;325:1511–1512. - PubMed
1. Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364:1293–1304. - PubMed
1. Tansey CM, Louie M, Loeb M, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. 2007;167:1312–1320. - PubMed
1. Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220–232. - PMC - PubMed
1. Morin L, Savale L, Pham T, et al. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021;325:1525–1534. - PMC - PubMed